ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
The AMA secured key provisions in CMS’s 2027 Medicare Advantage final rule, including a 2.48% payment increase and updated Star Ratings.
The AMA secured key provisions in CMS’s 2027 Medicare Advantage final rule, including a 2.48% payment increase and updated Star Ratings.
The AMA secured key provisions in CMS’s 2027 Medicare Advantage final rule, including a 2.48% payment increase and updated Star Ratings.
The AMA secured key provisions in CMS’s 2027 Medicare Advantage final rule, including a 2.48% payment increase and updated Star Ratings.
The AMA secured key provisions in CMS’s 2027 Medicare Advantage final rule, including a 2.48% payment increase and updated Star Ratings.
The AMA secured key provisions in CMS’s 2027 Medicare Advantage final rule, including a 2.48% payment increase and updated Star Ratings.
Read More
The Pennsylvania House Health Committee voted on HB 916 to update childhood blood lead testing requirements statewide.
Read More
Over 2,500 physicians and addiction experts gathered in Atlanta for the 13th annual Rx and Illicit Drug Summit to address the opioid crisis.
Read More
The FDA and CMS launched the RAPID pathway to speed Medicare coverage decisions for breakthrough medical devices through aligned reviews.
Read More
Breast cancer cases in U.S. women under 50 increased 1.4% annually from 2012-2022, driven by aggressive tumors and advanced-stage diagnoses.
Read More
CMS finalized the 2027 Medicare Advantage rule, enhancing quality and access but reducing plan accountability by removing some performance metrics.
Read More
A UK study of 360,000 adults found healthy sleep patterns linked to a 26% lower risk of pneumonia over 13 years.
Read MoreAs AI overviews from Google and ChatGPT increasingly answer patient health questions, concerns mount over inadvertent HIPAA exposure and misattribution that can erode clinic brand authority. Medical marketing teams must now track these risks into 2027.
Read More
HHS Secretary Kennedy defended the $111.1B FY 2027 budget prioritizing chronic disease prevention and Most Favored Nation drug pricing.
Read More
An OIG audit found CMS lacked sufficient oversight of compounded drugs in Medicare Part D from 2017-2019 due to incomplete data and reporting gaps.
Read More
